Evidence map›Paper›PMID 40221893›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2025

C-terminal frameshift variants in GPKOW are associated with a multisystemic X-linked disorder.

Jung-Wan Mok, Laura Mackay, Maria Blazo, Elizabeth Mizerik, Jozef Gecz, Renee Carroll, Mathilde Nizon, Sophie Rondeau, Madeleine Joubert, Silvestre Cuinat and 15 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jung-Wan MokDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX.
Laura MackayDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Genetics Department, Texas Children's Hospital, Houston, TX.
Maria BlazoBaylor Scott and White Medical Center, Temple, TX.
Elizabeth MizerikDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Genetics Department, Texas Children's Hospital, Houston, TX.
Jozef GeczAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, Australia.
Renee CarrollAdelaide Medical School and the Robinson Research Institute, University of Adelaide, Adelaide, Australia.
Mathilde NizonService de Génétique Médicale, CHU Nantes, Nantes Université, Nantes, France; L'institut du thorax, INSERM, CNRS, Nantes Université, Nantes, France.
Sophie RondeauReference Center for Skeletal Dysplasia, Necker-Enfants Malades Hospital, AP-HP, Paris, France.
Madeleine JoubertUF of Fœtopathology and Genetics, CHU Nantes, Nantes, France; Department of Anatomical Pathology, CHU Nantes, Nantes, France.
Silvestre CuinatService de Génétique Médicale, CHU Nantes, Nantes Université, Nantes, France.
Wallid DebService de Génétique Médicale, CHU Nantes, Nantes Université, Nantes, France; L'institut du thorax, INSERM, CNRS, Nantes Université, Nantes, France.
Fernanda Valle SiriasRice University, Houston, TX.
Monika Weisz-HubshmanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Genetics Department, Texas Children's Hospital, Houston, TX.
Shamika KetkarDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Urszula PolakDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Alyssa A TranDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Debra KearneyDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX.
Neil A HanchardDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Oguz KancaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX.
Michael F WanglerDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX.
Brendan H LeeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Genetics Department, Texas Children's Hospital, Houston, TX.
Baylor College of Medicine Center for Precision Medicine Models
Shinya YamamotoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX; Department of Neuroscience, Baylor College of Medicine, Houston, TX. Electronic address: yamamoto@bcm.edu.
Keren MacholDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Genetics Department, Texas Children's Hospital, Houston, TX. Electronic address: machol@bcm.edu.

Funding

Resource and Service SectionU54OD030165 · OD · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney · 2020 to 2026
$16.6M
Expansion and characterization of the Drosophila Toolkit to study SARS-CoV-2R24OD022005 · OD · BAYLOR COLLEGE OF MEDICINE · PI BELLEN, HUGO J · 2016 to 2023
$7.4M
A Comprehensive Resource for Manipulating the Drosophila GenomeR24OD031447 · OD · BAYLOR COLLEGE OF MEDICINE · PI HUGO J BELLEN, Oguz Kanca · 2021 to 2026
$5.2M
NIH HHS R24 OD022005NIH HHS R24 OD031447NIH HHS U54 OD030165
6 · The paper itself

Abstract

purposeGPKOW, a gene on the X-chromosome, encodes a nuclear RNA-binding protein important in messenger RNA (mRNA) processing as a spliceosome subunit. This work aims to establish GPKOW as a disease-associated gene.

methodsWe describe 3 males from 2 unrelated families with hemizygous frameshift variants affecting the last exon of GPKOW p.(Arg441SerfsTer30) and p.(Ser444GlufsTer28). The effect of p.(Ser444GlufsTer28) on gene expression was evaluated in patient's fibroblasts. In vivo studies in Drosophila melanogaster targeting the sole GPKOW fly ortholog, CG10324 (Gpkow) were performed.

resultsClinical presentations included intrauterine growth restriction, microcephaly/microencephaly, and eye, brain, skin, and skeletal abnormalities. Heterozygote females presented with short stature, microcephaly, and vision problems. Sequencing of fibroblasts' mRNA confirmed that GPKOW mRNA escapes nonsense-mediated decay. Yet, reduced protein levels suggested protein instability. Studies in Drosophila showed that Gpkow is essential and broadly expressed. It is enriched in neurons and glia in eyes and head of developing and adult flies. Knockdown and overexpression of Gpkow in the fly eye cause eyeless/headless phenotype, suggesting that the gene is dosage sensitive. Importantly, overexpression of the p.(Ser444GlufsTer28) variant caused milder defects than the reference allele, indicating that the truncated protein behaves as a partial loss-of-function allele.

conclusionRare variants in GPKOW cause a multisystemic X-linked syndrome.

Indexed as

Frameshift MutationGenetic Diseases, X-LinkedRNA-Binding ProteinsAnimalsChildDrosophila melanogasterDrosophila ProteinsFemaleFibroblastsHumansMaleMicrocephalyPedigreePhenotypeDrosophila ProteinsRNA-Binding ProteinsCG10324Drosophila melanogasterGPKOWMinor SpliceosomeNeurodevelopment

Identifiers

PMID40221893
PMCPMC12435177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.